Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
A phase 2 trial of Scalp cooling in Breast cancer, run by Hospital San Carlos, Madrid, completed.
Overview
Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling is a phase 2 interventional study registered as NCT00515762 by Hospital San Carlos, Madrid, with 150 participants recorded, started 2007-05 and reaching its primary completion in 2010-06. Interventions recorded: elasto-gel cap. Conditions recorded: Alopecia, Breast Cancer.
Linked to the technology Scalp cooling because the registry's title names it ("scalp cooling") and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
- TrialScalp Cooling in MBC
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types) and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- CompanyDignitana
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types).
- CompanyPaxman
Shares Scalp cooling (cold caps: DigniCap, Paxman), Breast cancer (all types).
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- Trial[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Shares Breast cancer (all types) and the tag pipeline.